Madrigal Pharmaceuticals total non-operating income/expense for the twelve months ending June 30, 2024 was $0.020B, a 2738.05% increase year-over-year.
Madrigal Pharmaceuticals annual total non-operating income/expense for 2023 was $0.007B, a 485.95% decline from 2022.
Madrigal Pharmaceuticals annual total non-operating income/expense for 2022 was $-0.002B, a 379.72% decline from 2021.
Madrigal Pharmaceuticals annual total non-operating income/expense for 2021 was $0.001B, a 85.64% decline from 2020.
Madrigal Pharmaceuticals Total Non-Operating Income/Expense 2010-2024 | MDGL